MIAMI--(BUSINESS WIRE)--Nov. 4, 2005--SFBC International, Inc. (NASDAQ: SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, announced today that is initiating an open market share repurchase program to purchase up to 1,000,000 shares of common stock depending upon market conditions.